C Reactive Protein in Home Quarantined Coronavirus Disease 2019 (COVID -19) Patients.

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

April 15, 2021

Primary Completion Date

May 9, 2021

Study Completion Date

June 6, 2021

Conditions
COVID -19
Interventions
DRUG

Oral Antibiotic, Antihistamine, Anti-inflammatory, Multivitamins

Oral Azithromycin , Cetirizine, Paracetamol, Zinc, Vitamin C, Vitamin D

DRUG

Oral low dose steroid

Low dose oral methyl prednisolone was added.

DRUG

Intravenous Antibiotics with Low dose steroid.

Intravenous ceftriaxone with either oral methyl prednisolone or intravenous dexamethasone was given

DRUG

Oral anti-coagulant

Rivaroxaban was given for minimum 4 weeks depending on D dimer levels

Trial Locations (1)

Unknown

ONLINE, Puducherry

All Listed Sponsors
collaborator

UR Anoop Research Group

OTHER

lead

Manimarane Arjunan, MD,DM (Cardiology)

OTHER